|
業務類別
|
Biotechnology |
|
業務概覽
|
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI. |
| 公司地址
| 50 rue de Dijon, Daix, FRA, 21121 |
| 電話號碼
| +33 380447500 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.inventivapharma.com |
| 員工數量
| 119 |
| Dr. Kristina Meyer, PhD |
Executive Vice President, Business Development and Alliance Management |
-- |
15/04/2025 |
| Dr. Pascaline Clerc, PhD |
Executive Vice President, Strategy and Corporate Affairs |
-- |
15/04/2025 |
| Mr. Frederic Cren |
Director and Chief Executive Officer |
歐元 311.12K |
15/04/2025 |
| Dr. Pierre Broqua, PhD |
Chief Scientific Officer and Deputy Chief Executive Officer |
歐元 249.72K |
15/04/2025 |
| Mr. Jean Volatier |
Chief Financial Officer and Deputy General Manager |
-- |
15/04/2025 |
| Mr. Michael Cooreman |
Chief Medical Officer |
-- |
15/04/2025 |
| Ms. Alice Roudot-Ketelers |
Chief Operating Officer |
-- |
15/04/2025 |
| Mr. Eric Duranson |
General Counsel |
-- |
15/04/2025 |
| Ms. Nathalie Harroy |
Head of Human Resources |
-- |
15/04/2025 |
|
|
| Dr. Mark Pruzanski, M.D. |
Chairman of the Board |
15/04/2025 |
| Dr. Lucy Lu, M.D. |
Independent Director |
15/04/2025 |
| Mr. G. Andre Turenne |
Independent Director |
15/04/2025 |
| Dr. Annick Schwebig |
Independent Director |
15/04/2025 |
| Mr. Heinz Christoph Maeusli |
Independent Director |
15/04/2025 |
| Mr. Frederic Cren |
Director and Chief Executive Officer |
15/04/2025 |
| Dr. Srinivas Akkaraju, M.D.,PhD |
Independent Director |
15/04/2025 |
| Ms. Martine Zimmermann, Pharm.D. |
Independent Director |
15/04/2025 |
|
|
|
|
